Sign in
4

Changes in Ownership

Nurix Therapeutics, Inc. Filed Acc 0001209191-21-055171

Chief Scientific Officer sold 1,600 shares at $35.00 ($56,000)

  • Chief Scientific Officer acquired 1,600 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hansen Gwenn · Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-09-07 Exercise or conversion : show line 1 in the form +1,600 $7.26 $11,616 15,797 D
2021-09-07 Sale : show line 2 in the form −1,600 $35.00 $56,000 14,197 D
Open-market sales · 1,600 sh · avg $35.00 · $56,000

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-09-07 Exercise or conversion : show line 3 in the form Employee Stock Option (right to buy) −1,600 69,466 D
Loading xslF345X03/doc4.xml…